AU2002211678A1 - Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype - Google Patents
Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotypeInfo
- Publication number
- AU2002211678A1 AU2002211678A1 AU2002211678A AU1167802A AU2002211678A1 AU 2002211678 A1 AU2002211678 A1 AU 2002211678A1 AU 2002211678 A AU2002211678 A AU 2002211678A AU 1167802 A AU1167802 A AU 1167802A AU 2002211678 A1 AU2002211678 A1 AU 2002211678A1
- Authority
- AU
- Australia
- Prior art keywords
- apolipoprotein
- phenotype
- lysis
- controlling
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24017400P | 2000-10-13 | 2000-10-13 | |
US60240174 | 2000-10-13 | ||
PCT/US2001/031909 WO2002030454A1 (en) | 2000-10-13 | 2001-10-12 | Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002211678A1 true AU2002211678A1 (en) | 2002-04-22 |
Family
ID=22905425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002211678A Abandoned AU2002211678A1 (en) | 2000-10-13 | 2001-10-12 | Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype |
Country Status (3)
Country | Link |
---|---|
US (1) | US7135305B2 (en) |
AU (1) | AU2002211678A1 (en) |
WO (1) | WO2002030454A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002214644A1 (en) * | 2000-10-13 | 2002-04-22 | University Of Cincinnati | Methods for enhancing lysing of coagulated blood with apolipoprotein e2 phenotype |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6313089B1 (en) * | 1997-08-20 | 2001-11-06 | Duke University | Complexes of apolipoprotein E and ciliary neurotrophic factor (CNTF) and methods of use |
US6046381A (en) * | 1998-04-30 | 2000-04-04 | The Regents Of The University Of California | Apolipoprotein E transgenic mice and assay methods |
AU2002214644A1 (en) * | 2000-10-13 | 2002-04-22 | University Of Cincinnati | Methods for enhancing lysing of coagulated blood with apolipoprotein e2 phenotype |
-
2001
- 2001-10-12 WO PCT/US2001/031909 patent/WO2002030454A1/en active Application Filing
- 2001-10-12 US US10/398,882 patent/US7135305B2/en not_active Expired - Lifetime
- 2001-10-12 AU AU2002211678A patent/AU2002211678A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7135305B2 (en) | 2006-11-14 |
US20040102374A1 (en) | 2004-05-27 |
WO2002030454A1 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002320730A1 (en) | Methods and apparatuses for navigating the subarachnoid space | |
WO2001070230A3 (en) | Compounds with 5-ht activity useful for controlling visual field loss | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU2002227144A1 (en) | System and method for controlling patient temperature | |
AU3004000A (en) | Methods for the treatment of apolipoprotein e related diseases | |
AU2000279747A1 (en) | Emulsion of perfluororganic compounds for medical purposes, method for producingsaid emulsion and methods for curing and preventing diseases with the aid of the emulsion | |
AU2002211678A1 (en) | Methods for controlling the lysis of coagulated blood with apolipoprotein e4 phenotype | |
AU2002214644A1 (en) | Methods for enhancing lysing of coagulated blood with apolipoprotein e2 phenotype | |
AU2841500A (en) | Dehiscence gene and methods for regulating dehiscence | |
AU2002321730A1 (en) | Enterovirus nucleic acids and methods for detecting enterovirus | |
AU2002245350A1 (en) | Methods for determining the genetic affinity of microorganisms and viruses | |
AU2002355155A1 (en) | Methods for gene disruption and uses thereof | |
AU2001268108A1 (en) | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders | |
AU2001259595A1 (en) | Haplotypes of the crybb1 gene | |
AU2003255504A1 (en) | Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors | |
AU2002320835A1 (en) | Brain expressed gene and protein associated with bipolar disorder | |
AU2001284680A1 (en) | Haplotypes of the alas2 gene | |
AU2001253560A1 (en) | Methods of treatment | |
AU2002246509A1 (en) | Method for controlling the manufacture of polycarbonate and the polycarbonate formed thereby | |
AU2001290603A1 (en) | Haplotypes of the or11a1 gene | |
AU2002239511A1 (en) | Haplotypes of the gsr gene | |
AU2002360156A1 (en) | Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents | |
AU2001250530A1 (en) | Treatment of conditions of the central nervous system using mycobacteria | |
AU2001264719A1 (en) | Haplotypes of the aanat gene | |
AU2001290575A1 (en) | Haplotypes of the tacr1 gene |